Clinical trial reportThe oncologistPublished
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial
Regional connection
Verified Author affiliations on the Europe PMC record name Fox Chase Cancer Center, Jefferson Health, Thomas Jefferson University, with Temple Health linked by the institution reference. Affiliation source
- Counties
- Montgomery County, Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- The oncologist
- Published
- Topic
- Clinical care
- Subject terms
- Esophagogastric Junction; Humans; Esophageal Neoplasms; Stomach Neoplasms; Paclitaxel; Antineoplastic Combined Chemotherapy Protocols; Antibodies, Monoclonal, Humanized; Esophageal; Insulin-like growth factor-1 receptor; Gastroesophageal Junction; Xixutumumab
- PubMed ID
- 37104870
- PubMed Central ID
- PMC10485278
- Open access
- Yes, open
- Added to directory
- Source checked